(RMBS) Rambus - Ratings and Ratios
DDR Interface Chips, Silicon IP, Security IP, Patents
RMBS EPS (Earnings per Share)
RMBS Revenue
Description: RMBS Rambus
Rambus Inc. is a semiconductor company that designs and licenses high-performance memory and interface technologies. The companys product portfolio includes DDR5 and DDR4 memory interface chips, silicon IP solutions for data center, government, and automotive applications, and a portfolio of patents covering memory architecture and security products. Rambus Inc. sells its products to major industry players, including memory module manufacturers, OEMs, hyperscalers, and chip makers.
From a business perspective, Rambus Inc. has a diversified revenue stream with a mix of product sales and licensing fees. The companys focus on high-performance memory and interface technologies positions it well for growth in emerging markets such as data centers, artificial intelligence, and autonomous vehicles. Key performance indicators (KPIs) to watch include revenue growth, gross margin expansion, and the companys ability to maintain its patent portfolio and licensing revenue. Additionally, metrics such as customer concentration, product mix, and research and development (R&D) expenses as a percentage of revenue will be important to monitor.
To further analyze Rambus Inc.s performance, we can examine its return on equity (RoE) of 19.06%, which indicates a relatively strong return on shareholder capital. The companys forward price-to-earnings (P/E) ratio of 20.45 suggests that the market expects earnings growth in the future. Other relevant KPIs include the companys operating cash flow margin, debt-to-equity ratio, and the percentage of revenue derived from licensing fees versus product sales. By analyzing these metrics, we can gain a deeper understanding of Rambus Inc.s financial health and growth prospects.
RMBS Stock Overview
| Market Cap in USD | 9,256m |
| Sub-Industry | Semiconductors |
| IPO / Inception | 1997-05-14 |
RMBS Stock Ratings
| Growth Rating | 88.1% |
| Fundamental | 89.4% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 113% |
| Analyst Rating | 4.75 of 5 |
RMBS Dividends
Currently no dividends paidRMBS Growth Ratios
| Growth Correlation 3m | 87.7% |
| Growth Correlation 12m | 69.3% |
| Growth Correlation 5y | 86.8% |
| CAGR 5y | 57.29% |
| CAGR/Max DD 3y | 1.17 |
| CAGR/Mean DD 3y | 3.96 |
| Sharpe Ratio 12m | 0.70 |
| Alpha | 0.01 |
| Beta | 0.875 |
| Volatility | 69.01% |
| Current Volume | 2425.5k |
| Average Volume 20d | 1387.6k |
| Stop Loss | 93 (-4.6%) |
| Signal | 0.27 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (229.1m TTM) > 0 and > 6% of Revenue (6% = 38.7m TTM) |
| FCFTA 0.18 (>2.0%) and ΔFCFTA 2.43pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 110.2% (prev 110.0%; Δ 0.26pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.20 (>3.0%) and CFO 292.8m > Net Income 229.1m (YES >=105%, WARN >=100%) |
| Net Debt (-59.8m) to EBITDA (299.2m) ratio: -0.20 <= 3.0 (WARN <= 3.5) |
| Current Ratio 10.85 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (108.6m) change vs 12m ago -0.37% (target <= -2.0% for YES) |
| Gross Margin 80.29% (prev 76.71%; Δ 3.58pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 47.49% (prev 38.18%; Δ 9.31pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 179.6 (EBITDA TTM 299.2m / Interest Expense TTM 1.44m) >= 6 (WARN >= 3) |
Altman Z'' 4.22
| (A) 0.48 = (Total Current Assets 783.8m - Total Current Liabilities 72.2m) / Total Assets 1.47b |
| (B) -0.02 = Retained Earnings (Balance) -35.4m / Total Assets 1.47b |
| (C) 0.19 = EBIT TTM 258.2m / Avg Total Assets 1.36b |
| (D) -0.15 = Book Value of Equity -36.1m / Total Liabilities 239.8m |
| Total Rating: 4.22 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 89.38
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 2.97% = 1.48 |
| 3. FCF Margin 40.60% = 7.50 |
| 4. Debt/Equity 0.14 = 2.49 |
| 5. Debt/Ebitda 0.58 = 2.25 |
| 6. ROIC - WACC (= 11.35)% = 12.50 |
| 7. RoE 20.15% = 1.68 |
| 8. Rev. Trend 87.13% = 6.53 |
| 9. EPS Trend 59.05% = 2.95 |
What is the price of RMBS shares?
Over the past week, the price has changed by +26.47%, over one month by +28.71%, over three months by +62.70% and over the past year by +152.32%.
Is Rambus a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of RMBS is around 126.51 USD . This means that RMBS is currently undervalued and has a potential upside of +29.73% (Margin of Safety).
Is RMBS a buy, sell or hold?
- Strong Buy: 7
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the RMBS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 81.9 | -16% |
| Analysts Target Price | 81.9 | -16% |
| ValueRay Target Price | 141.8 | 45.4% |
Last update: 2025-09-13 05:04
RMBS Fundamental Data Overview
CCE Cash And Equivalents = 594.8m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 40.7725
P/E Forward = 20.4499
P/S = 14.34
P/B = 7.763
P/EG = 3.8007
Beta = 1.375
Revenue TTM = 645.5m USD
EBIT TTM = 258.2m USD
EBITDA TTM = 299.2m USD
Long Term Debt = 167.6m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 5.97m USD (from shortTermDebt, last quarter)
Debt = 173.6m USD (Calculated: Short Term 5.97m + Long Term 167.6m)
Net Debt = -59.8m USD (from netDebt column, last quarter)
Enterprise Value = 8.84b USD (9.26b + Debt 173.6m - CCE 594.8m)
Interest Coverage Ratio = 179.6 (Ebit TTM 258.2m / Interest Expense TTM 1.44m)
FCF Yield = 2.97% (FCF TTM 262.1m / Enterprise Value 8.84b)
FCF Margin = 40.60% (FCF TTM 262.1m / Revenue TTM 645.5m)
Net Margin = 35.49% (Net Income TTM 229.1m / Revenue TTM 645.5m)
Gross Margin = 80.29% ((Revenue TTM 645.5m - Cost of Revenue TTM 127.2m) / Revenue TTM)
Tobins Q-Ratio = -244.9 (set to none) (Enterprise Value 8.84b / Book Value Of Equity -36.1m)
Interest Expense / Debt = 0.22% (Interest Expense 382.0k / Debt 173.6m)
Taxrate = 10.11% (20.2m / 200.0m)
NOPAT = 232.1m (EBIT 258.2m * (1 - 10.11%))
Current Ratio = 10.85 (Total Current Assets 783.8m / Total Current Liabilities 72.2m)
Debt / Equity = 0.14 (Debt 173.6m / last Quarter total Stockholder Equity 1.23b)
Debt / EBITDA = 0.58 (Net Debt -59.8m / EBITDA 299.2m)
Debt / FCF = 0.66 (Debt 173.6m / FCF TTM 262.1m)
Total Stockholder Equity = 1.14b (last 4 quarters mean)
RoA = 15.61% (Net Income 229.1m, Total Assets 1.47b )
RoE = 20.15% (Net Income TTM 229.1m / Total Stockholder Equity 1.14b)
RoCE = 19.80% (Ebit 258.2m / (Equity 1.14b + L.T.Debt 167.6m))
RoIC = 20.42% (NOPAT 232.1m / Invested Capital 1.14b)
WACC = 9.07% (E(9.26b)/V(9.43b) * Re(9.24%)) + (D(173.6m)/V(9.43b) * Rd(0.22%) * (1-Tc(0.10)))
Shares Correlation 3-Years: -78.79 | Cagr: -0.27%
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
[DCF Debug] Terminal Value 74.80% ; FCFE base≈234.4m ; Y1≈245.7m ; Y5≈286.2m
Fair Price DCF = 37.74 (DCF Value 4.06b / Shares Outstanding 107.6m; 5y FCF grow 5.16% → 3.0% )
EPS Correlation: 59.05 | EPS CAGR: 323.7% | SUE: 0.07 | # QB: 0
Revenue Correlation: 87.13 | Revenue CAGR: 16.84% | SUE: 0.63 | # QB: 0
Additional Sources for RMBS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle